v3.25.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating Activities:    
Net income/(loss) $ (3,739,693) $ (5,983,569)
Adjustments to reconcile net income (loss) to cash used in operating activities:    
Depreciation and amortization 34,352 39,408
Share-based compensation 615,492 444,924
Stock issued for services   38,500
Stock issued for warrant settlement   743,459
Operating lease asset amortization 265,343 234,818
Amortization of debt discount 2,780 64,017
Loss on equity method investment 1,579 1,702
Inventory reserve expense (8,286) (35,915)
Impairment loss   524,481
Gain on settlement of liability, net (35,039)  
Other   (14,941)
Changes in operating assets and liabilities:    
Accounts receivable (12,821) (22,324)
Inventories 3,508 22,555
Prepaid expenses and other current assets (134,099) (109,774)
Accounts payable 138,146 77,903
Related party payable   1,538
Operating lease liabilities (280,450) (238,387)
Accrued interest 24,184 10,488
Accrued expenses (236,540) (645,348)
Net cash used in operating activities (3,361,544) (4,846,465)
Investing Activities:    
Payments on purchase of assets (2,515)  
Net cash used in investing activities (2,515)  
Financing Activities:    
Proceeds from bridge loans   1,153,750
Repayment of bridge loans (22,335) (560,756)
Proceeds from issuance of Common Stock 3,566,594 14,046,758
Financing issuance cost (396,084) (1,250,298)
Warrant repurchase   (3,600,000)
Payment of convertible notes, cash payable, and other payable   (206,664)
Net cash provided by (used in) financing activities 3,148,175 9,582,790
Net change in cash and cash equivalents (215,884) 4,736,325
Cash and cash equivalents at beginning of period 3,170,743 1,048,733
Cash and cash equivalents at end of period 2,954,859 5,785,058
Non-Cash Transactions:    
Exercise of prefunded warrants   2,188
Non-cash conversions of convertible notes to equity   1,256,692
Supplemental disclosure of cash flow information:    
Interest $ 446 $ 258,000